Chr. Hansen Holding — Board/Management Information 2016

Dec 6, 2016

Hoersholm, 2016-12-06 15:16 CET (GLOBE NEWSWIRE) --

Company announcement No. 25/2016

Chr. Hansen Holding A/S has entered into an agreement with Thomas Schäfer to
take up the position of Executive Vice President and Chief Scientific Officer.

Thomas is currently employed as Vice President at Novozymes and will take up
his new position as soon as possible, which is expected to be during spring
2017.

A German national, Thomas completed his Ph.D. in Microbiology, Physiology &
Biochemistry and worked as an assistant professor at Freie Universität Berlin.
He started his commercial career as a post doc and has since 1994 held various
senior leadership positions in the R&D space at Novozymes.

Thomas has more than 20 years’ experience in industrial microbiology, R&D,
Innovation, business development and M&A, covering both bacteria and enzymes.
He has published several papers, and is the co-founder of a number of patents.

Cees de Jong, CEO of Chr. Hansen, says: “I’m pleased to welcome Thomas to Chr.
Hansen as we continue to strengthen our capabilities within the microbial
platform and our leadership position in bacterial fermentation technology.”

Following this appointment, the Executive Board will consist of: CEO Cees de
Jong, CFO Søren Westh Lonning, COO Knud Vindfeldt, and CSO Thomas Schäfer.

For further information, please contact:

Anders Mohr Christensen, Senior Director, Investor Relations
Tel: +45 4574 7618

Camilla Lercke, Head of Media Relations

Tel: +45 5339 2384

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient
solutions for the food, nutritional, pharmaceutical and agricultural
industries. The products include cultures, enzymes, probiotics and natural
colors, and all solutions are based on strong research and development
competencies coupled with significant technology investments. Revenue in the
2015/16 financial year was EUR 949 million. The company has more than 2,700
dedicated employees in 30 countries and main production facilities in Denmark,
France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on
Nasdaq Copenhagen A/S. For further information, please visit
www.chr-hansen.com.